Research

The research shows a sharp uptick in young children going to hospital, in the period after legal edibles came to market

The stronger preference for flower is steady across demographics

Currently treatments are largely insufficient, so care providers encourage more research despite stigma

Canadians' attitudes haven't shifted much over the past year

Lockdowns and stimulus cheques were responsible for an irregular boost in buying weed

Some study participants stopped using cannabis out of fear of potential harm to the fetus, while others stopped because of social stigma, guilt and health reasons

Olorinab is a CB2 receptor agonist in a Phase 2 trial for IBS

The Indigenous-led research team has partnered with Woodland Cree First Nation and Indigenous Bloom

A majority of cannabis consumers combine weed and working out, according to earlier research

Compared to non-consumers, people who used cannabis 20 days a month were more likely to experience both extremes of sleep duration

The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services

And some terpenes have painkilling effects without interacting with cannabinoid receptors

While THC can cause temporary dose-dependent psychotic symptoms, researchers note that some clinical findings suggest CBD has a different effect

Terpenes are only part of what gives some types of weed their unique smells and other related properties

The research casts doubt on currently used methods for detecting impairment

There are more than 3,800 studies on weed published this year already, surpassing a record set in 2020

Research funded by MindMed suggests some antidepressants can reduce the unwanted side effects of psychedelics

The methods will be available as part of third-party client services

In spite of warnings from major agencies on the dangers of delta-8 THC, researchers say it has therapeutic potential

Some are criticizing researcher Stamets for trying to capitalize on the phenomenon of 'stacking,' where psychedelics are paired with health supplements

A total 27 million cannabis vape units were sold over the three-month period in both countries, generating over US$900 million in revenue

72% of cannabis users say that everyone, or almost everyone, they know consumes cannabis

Cannabis sales have been 25% higher than estimated revenue if the pandemic didn't happen

Cannabis and 'classical' psychedelics could act on similar receptors

While there's only limited data on the effects of cannabis in minors, researchers suggest it as an alternative to surgery in severe cases

But weed farmers face barriers to many of the subsidies and services afforded to other agricultural businesses

Whether dressing up for a night on the town, or curling up for a scary movie at home, many will supplement their celebrations with weed

But terpenes might be tempering the process

Data was collected via the Strainprint app, and is some of the first research of its kind to focus on regulated products

Since edibles have only been legal in Canada since 2019, there's a lack of scientific data

Several of the common smell-producing compounds in cannabis are associated with analgesic properties, and have attractive safety profiles

It’s the first federal grant to be awarded for psychedelic treatment research in 50 years

After a spike in demand for research, the DEA is proposing increased quotas for controlled substances including MDMA, LSD, psilocybin and cannabis

A majority of physicians aren't equipped to talk about medical cannabis, and patients often look for information elsewhere

Taking sublingual oils proved beneficial for chronic pain, nausea, anxiety and a list of other common ailments

On average, unregulated bud tested had 10%-lower THC than advertised

A study linked self reports of being stoned with time and movement in young adults

The firm says expenses will increase as research and 'important progress' continues

According to data firm BDSA, rapid expansion of US markets is the primary driver of cannabis sales growth over the next 5 years

The Cross-Party Group on Medical Cannabis hopes to shed light on developing treatments